Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.5M Buy
+48,300
New +$4.28M 0.01% 946
2025
Q4
Sell
-5,100
Closed -$498K 2768
2025
Q3
$498K Sell
5,100
-15,800
-76% -$1.27M ﹤0.01% 2147
2025
Q2
$1.46M Buy
+20,900
New +$1.19M ﹤0.01% 1608
2025
Q1
Sell
-7,400
Closed -$517K 2924
2024
Q4
$517K Buy
+7,400
New +$615K ﹤0.01% 2135

Other funds holding ACLS

PEAK6's ACLS Position: Q4 2025 in Review

PEAK6 sold out of Axcelis (ACLS) in Q4 2025, closing a stake of 1,005 shares — an estimated $98.1K sold.

PEAK6 first reported a position in ACLS in Q4 2024 and held it in 4 quarters. The position peaked at $810K in Q2 2025. 370 funds tracked by Wall St. Rank hold ACLS as of Q4 2025.

  • PEAK6 reported no remaining Axcelis position as of Q4 2025 after selling out during the quarter.
  • PEAK6 sold 1,005 Axcelis shares in Q4 2025, an estimated $98.1K.
  • PEAK6 first reported a position in Axcelis in Q4 2024 and held it in 4 quarters.
  • PEAK6's Axcelis position peaked at $810K in Q2 2025.
  • 370 funds tracked by Wall St. Rank held Axcelis as of Q4 2025.

Based on PEAK6's 13F filing for Q4 2025, filed 13 Feb 2026.